A Study of LY2510924 and Sunitinib in Patients With Metastatic Renal Cell Carcinoma

Clinical trial NCT01391130 · TERMINATED

Trial details

NCT number: NCT01391130
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Clear Cell Renal Cell Carcinoma

Start date: 2011-08-01
Primary completion: 2014-09-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.